No abstract available
Publication types
-
Letter
-
Multicenter Study
-
Randomized Controlled Trial
-
Research Support, N.I.H., Extramural
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Adolescent
-
Adult
-
Antineoplastic Combined Chemotherapy Protocols / administration & dosage*
-
Antineoplastic Combined Chemotherapy Protocols / adverse effects
-
Child
-
Child, Preschool
-
Cytarabine / administration & dosage
-
Cytarabine / adverse effects
-
Daunorubicin / administration & dosage
-
Daunorubicin / adverse effects
-
Disease-Free Survival
-
Etoposide / administration & dosage
-
Etoposide / adverse effects
-
Female
-
Humans
-
Infant
-
Infant, Newborn
-
Leukemia, Myeloid, Acute* / blood
-
Leukemia, Myeloid, Acute* / drug therapy
-
Leukemia, Myeloid, Acute* / mortality
-
Leukocytosis* / blood
-
Leukocytosis* / drug therapy
-
Leukocytosis* / mortality
-
Male
-
Survival Rate
Substances
-
Cytarabine
-
Etoposide
-
Daunorubicin